fda approved glp 1 for weight loss The a new GLP-1 pill called Foundayo (orforglipron) adults with obesity or who are overweight and have weight-related health issues: https://bit.ly/4toaoTl The FDA has approved the
Description
You may have heard of it by its brand names, Zepbound or Mounjaro
These differences mean that semaglutide safety data cannot be automatically applied to tirzepatide and vice versa
Because pill-based GLP-1 options are easier to initiate, providers may consider them sooner in the disease progression
A review of the antimicrobial side of antidepressants and its putative implications on the gut microbiome
Klausen et al
